GlySens

GlySens Incorporated is a privately held company dedicated to developing the world's first truly long-term continuous blood glucose monitoring system, aiming to significantly improve the lives of people with diabetes. The GlySens ICGMTM system aims to provide individuals with diabetes a simple, seamless, and worry-free means of glucose monitoring by empowering them with the information they need to live life on their own terms. The GlySens ICGM system is currently undergoing clinical evaluation.